US11174275B2ActiveUtilityA1
Methods for the preparation of cyclopentaoxasilinones and cyclopentaoxaborininones and their use
Est. expiryAug 20, 2039(~13.1 yrs left)· nominal 20-yr term from priority
C07F 7/1876C07F 7/20C07F 5/025C07F 7/1892
42
PatentIndex Score
0
Cited by
35
References
15
Claims
Abstract
In various aspects and embodiments the invention provides a method of preparing a cyclopentaoxasilinone, the method comprising contacting a siloxy-tethered 1,7-enyne with a thioether promoter. In another aspect, the invention provides a method of preparing a cyclopentaoxaborininone, the method comprising contacting a boronic ester-tethered 1,7-enyne with a thioether promoter.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of preparing a cyclopentaoxasilinone or cyclopentaoxaborininone, the method comprising contacting a siloxy-tethered 1,7-enyne or a boronic ester-tethered 1,7-enyne of Formula (Ia) or Formula (Ib) with a thioether promoter to form a cyclopentaoxasilinone or cyclopentaoxaborininone of Formula (II);
wherein Formula (Ia) is as follows:
wherein
E is Si or B ;
R 10a and R 11a are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, halogen, C 1 -C 6 alkoxy, C 6 -C 12 aryloxy, C 6 -C 12 aryl, C 4 -C 10 heteroaryl, trialkylsilane, hydroxy, halogen, nitrile, C(═O)OR 15a , and combinations thereof;
R 12a is selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 6 -C 12 aryl, and combinations thereof;
R 13a and R 14a are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkoxy, hydroxy and combinations thereof, wherein R 13a and R 14a may optionally fuse or join to form a ring; and
R 15a is selected from the group consisting of hydrogen, deuterium, and C 1 -C 6 alkyl;
wherein Formula (Ib) is as follows:
wherein
M + is an alkali metal cation;
R 10b and R 11b are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, halogen, C 1 -C 6 alkoxy, C 6 -C 12 aryloxy, C 6 -C 12 aryl, C 4 -C 10 heteroaryl, trialkylsilane, hydroxy, halogen, nitrile, C(═O 0 )OR 15b , and combinations thereof;
R 12b and R 13b are each independently selected from the group consisting of C 1 -C 6 alkoxy, hydroxy, and combinations thereof, wherein R 12b and R 13b may optionally fuse or join to form a ring;
R 14b is selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 6 -C 12 aryl, and combinations thereof; and
R 15b is selected from the group consisting of hydrogen, deuterium, and C 1 -C 6 alkyl;
wherein Formula (II) is as follows:
wherein
is
E is Si or B;
R 20 and R 21 are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, hydroxy, halogen, C 1 -C 6 alkoxy, nitrile, C 6 -C 12 aryloxy, C 6 -C 12 aryl, C 4 -C 10 heteroaryl, trialkylsilane, hydroxy, halogen, nitrile, C(=O)OR 27 , and combinations thereof;
R 22 , R 23 , and R 25 are each present or absent, valency permitting, and each R 22 , R 23 , and R 25 present is independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkoxy, hydroxy, and combinations thereof;
R 24 and R 26 are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 6 -C 12 aryl, and combinations thereof; and
R 27 is selected from the group consisting of hydrogen, deuterium, and C 1 -C 6 alkyl; and
wherein when E in Formula (Ia) is Si the thioether promoter is 4-FBnSMe.
2. The method of claim 1 , wherein the thioether promoter is isolated and reused.
3. The method of claim 1 , wherein the thioether promoter is 4-FBnSMe.
4. The method of claim 1 , wherein a first diastereomer of the cyclopentaoxasilinone or cyclopentaoxaborininone is formed with higher selectivity than a second diastereomer of the cyclopentaoxasilinone or cyclopentaoxaborininone.
5. The method of claim 1 , wherein the step of contacting a siloxy-tethered 1,7-enyne or a boronic ester-tethered 1,7-enyne with a thioether promoter is by the step of contacting the siloxy-tethered 1,7-enyne or boronic ester-tethered 1,7-enyne with a transition metal carbonyl.
6. The method of claim 5 , wherein the transition metal carbonyl is dicobalt octacarbonyl.
7. The method of claim 1 , wherein the cyclopentaoxasilinone or cyclopentaoxaborininone of Formula (II) is a cyclopentaoxasilinone or cyclopentaoxaborininone of Formula (IIa)
wherein
E is Si or B;
R 20a is hydrogen or deuterium;
R 21a selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, hydroxy, halogen, C 1 -C 6 alkoxy, nitrile, C 6 -C 12 aryloxy, C 6 -C 12 aryl, C 4 -C 10 heteroaryl, trialkylsilane, hydroxy, halogen, C(═O)OR 25a , and combinations thereof,
R 22a and R 23a are each present or absent, valency permitting, and each R 22a and R 23a present is independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkoxy, hydroxy, and combinations thereof,
R 24a is selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 6 -C 12 aryl, and combinations thereof, and
R 25a is selected from the group consisting of hydrogen, deuterium, and C 1 -C 6 alkyl.
8. The method of claim 7 , wherein the cyclopentaoxasilinone or cyclopentaoxaborininone of Formula (IIa) comprises a greater amount of one diastereomer of Formula (IIa) over other diastereomers of Formula (IIa).
9. The method of claim 1 , wherein the cyclopentaoxaborininone of Formula (II) is a cyclopentaoxaborininone of Formula (IIb)
wherein
R 20b and R 21b are each independently selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, hydroxy, halogen, C 1 -C 6 alkoxy, nitrile, C 6 -C 12 aryloxy, C 6 -C 12 aryl, C 4 -C 10 heteroaryl, trialkylsilane, hydroxy, halogen, nitrile, C(═O)OR 24b , and combinations thereof;
R 22b is selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 6 -C 12 aryl, and combinations thereof;
R 23b is selected from the group consisting of hydrogen, deuterium, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkoxy, hydroxy, and combinations thereof, and
R 24b is selected from the group consisting of hydrogen, deuterium, and C 1 -C 6 alkyl.
10. The method of claim 9 , wherein the cyclopentaoxaborininone of Formula (IIb) comprises a greater amount of one diastereomer of Formula (IIb) over other diastereomers of Formula (IIb).
11. The method of claim 7 , wherein the cyclopentaoxasilinone is selected from the group consisting of
and combinations thereof,
wherein i-Pr is isopropyl, TMS is trimethylsilyl, MOM is methoxymethyl acetyl and Me is methyl.
12. The method of claim 1 , wherein the method further comprises the step of reacting the cyclopentaoxasilinone or cyclopentaoxaborininone with one or more additional reagents which oxidize, epoxidize, or reduce the cyclopentaoxasilinone or cyclopentaoxaborininone.
13. The method of claim 12 , wherein the cyclopentaoxasilinone or cyclopentaoxaborininone is oxidized to form a cyclopentenone.
14. The method of claim 1 , wherein the step contacting a siloxy-tethered 1,7-enyne with a thioether promoter further comprises the step of contacting the siloxy-tethered 1,7-enyne with carbon monoxide.
15. The method of claim 14 , wherein the step of contacting a siloxy-tethered 1,7-enyne with a thioether promoter is preceeded by the step of contacting the siloxy-tethered 1,7-enyne with dicobalt octacarbonyl.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.